Core Viewpoint - The company reported a significant decline in revenue and net profit for the first half of 2025, primarily due to accounting standards affecting trade business, while mining production remains stable [1][2]. Group 1: Financial Performance - In the first half of 2025, the company achieved a revenue of 1.709 billion HKD, a year-on-year decrease of 58% [1]. - The net profit attributable to shareholders was -68 million HKD, reflecting a year-on-year decline of 160% [1]. - The trade segment incurred a loss of 262 million HKD due to the impact of accounting practices and market price fluctuations [2]. Group 2: Uranium Market Dynamics - Natural uranium prices showed a steady fluctuation in the first half of 2025, with spot prices ranging between 60-80 USD per pound, averaging 78.50 USD per pound by the end of June, a 4% increase from the beginning of the year [1]. - Long-term contract prices remained stable at 80.00 USD per pound, supporting existing uranium mine production increases and restarts [1]. - Global uranium production is expected to grow by 13% year-on-year in 2024, reaching approximately 61,600 tons, but supply challenges are anticipated post-2028 due to long project lead times and resource depletion [1]. Group 3: Sales and Contracts - The company signed new contracts for 1,910 tons of natural uranium, with 53% of sales coming from Europe, 30% from Asia, and 17% from North America [2]. - The total delivery of natural uranium reached 812 tons, generating sales revenue of 1.23 million USD (approximately 9.55 million HKD) [2]. - As of June 30, 2025, the company held 1,569 tons of natural uranium with a weighted average cost of 68.77 USD per pound, and had 4,564 tons of signed but undelivered contracts at an average price of 80.52 USD per pound [2]. Group 4: Mining Operations - The company's mining operations demonstrated strong performance, achieving an equity production of 650 tons of standard uranium in the first half of 2025 [3]. - All invested mines exceeded 100% completion rates in the second quarter of 2025, indicating robust production capacity and effective cost control [3]. - New sales framework agreements for 2026-2028 reflect confidence in the uranium market, with a pricing mechanism of "30% fixed price + 70% spot price," enhancing revenue elasticity to uranium price fluctuations [3].

Market Trends - The domestic market indices showed a decline, with the Shanghai Composite Index closing at 3,765.88, down 1.25%, and the Shenzhen Component Index down 2.83% [4] - The overall market saw a significant increase in trading volume, with A-share transaction amounts reaching 14.92 trillion yuan, a 15.29% increase week-on-week [7] Industry Commentary - The non-bank financial sector reported a substantial increase in brokerage performance, with 42 listed brokerages achieving a total revenue of 251.87 billion yuan, a year-on-year increase of 11.37%, and a net profit of 104.02 billion yuan, up 65.08% [6][7] - The communication sector is experiencing a surge in demand, particularly driven by Alibaba Cloud's Q2 performance, which exceeded expectations with a revenue increase of 26% to 33.4 billion yuan [8] Company Insights - Huafeng Technology (688629.SH) reported a significant revenue increase of 128.26% year-on-year, reaching 1.105 billion yuan in H1 2025, with a net profit of 151 million yuan, up 940.64% [10] - China General Nuclear Power Corporation (01164.HK) faced a revenue decline of 58% to 1.709 billion HKD in H1 2025, primarily due to accounting standards affecting trade business [12] - Kangchen Pharmaceutical (603590.SH) achieved a revenue of 460 million yuan in H1 2025, reflecting a growth of 13.8% [14] - Longjiang Securities (000783.SZ) reported a significant recovery in investment business, with a notable increase in operating performance [28] Investment Recommendations - The report suggests a "Buy-B" rating for Huafeng Technology, anticipating continued growth in the domestic AI server market and communication modules [10][11] - For China General Nuclear Power, a "Buy-B" rating is maintained, with expectations of recovery in profitability driven by strategic contracts and market demand [13] - Kangchen Pharmaceutical is also rated "Buy-B," with projected revenue growth driven by innovative drug development [14] Future Projections - Huafeng Technology is expected to continue benefiting from the domestic AI server market, with projections indicating a strong performance in the coming years [10][11] - China General Nuclear Power anticipates a rebound in net profit, with estimates of 3.76 billion HKD in 2025, growing significantly in subsequent years [13] - Kangchen Pharmaceutical forecasts revenues of 9.41 billion yuan by 2027, indicating robust growth potential [14]

Investment Rating - The report maintains a "Buy-B" rating for the company, indicating a positive outlook on its stock performance relative to the market [3][7]. Core Views - The natural uranium market is stabilizing and showing an upward trend, driven by the demand for green energy [4]. - The company's trading business experienced a significant decline in revenue due to accounting standards affecting the timing of revenue recognition, but mining production remains steady [3][5]. - The company has signed new long-term contracts, reflecting strong confidence in the future uranium market [6]. Financial Performance - In the first half of 2025, the company reported a revenue of 1.709 billion HKD, a year-on-year decrease of 58%, and a net loss attributable to shareholders of 68 million HKD, a decline of 160% [3]. - The average price of natural uranium increased by 4% year-to-date, reaching an average of 78.50 USD per pound by the end of June 2025 [4]. - The company’s international sales division signed contracts for 1,910 tons of natural uranium, with 53% of sales coming from Europe [5]. Production and Expansion - The company achieved an equity production of 650 tons of standard uranium in the first half of 2025, with production rates exceeding 100% at its mining operations [6]. - New sales framework agreements for 2026-2028 have been established, adjusting pricing mechanisms to enhance performance elasticity against uranium prices [6]. Future Projections - The company is expected to achieve net profits of 410 million HKD, 850 million HKD, and 1 billion HKD for the years 2025, 2026, and 2027, respectively, with corresponding P/E ratios of 46, 22, and 19 [7][10].

股份發行人及根據《上市規則》第十九B章上市的香港預託證券發行人的證券變動月報表 截至月份: 2025年8月31日 狀態: 新提交 FF301 FF301 II. 已發行股份及/或庫存股份變動 致：香港交易及結算所有限公司 公司名稱: 中廣核礦業有限公司 呈交日期: 2025年9月4日 I. 法定/註冊股本變動 | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | | 於香港聯交所上市 (註1) | | 是 | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 證券代號 (如上市) | 01164 | 說明 | 不適用 | | | | | | | | | 法定/註冊股份數目 | | | 面值 | | 法定/註冊股本 | | | 上月底結存 | | | 50,000,000,000 | HKD | | 0.01 HKD | | 500,000,000 | | 增加 / 減少 (-) | | | | | | HKD | | | | 本月底結存 | | | 50,000,000,000 | HKD | | 0.01 HKD | | 500, ...

Group 1 - The Hong Kong Stock Exchange reported that on September 1, China State-owned Mixed Ownership Reform Fund Co., Ltd. reduced its stake in China General Nuclear Power Corporation Mining (01164) by 125.3 million shares at a price of HKD 2.67 per share, totaling approximately HKD 335 million [1] - After the reduction, the latest shareholding number is approximately 480 million shares, with a new ownership percentage of 6.32% [1] - The transaction involved other related parties, including China Chengtong Holdings Group Co., Ltd. and Chengda Holdings Limited [1]

Group 1 - The core point of the article is that China National Mixed Ownership Reform Fund Co., Ltd. has reduced its stake in China General Nuclear Power Corporation (CGN) Mining & Energy Co., Ltd. by selling 125.3 million shares at a price of HKD 2.67 per share, totaling approximately HKD 335 million [1] - After the reduction, the fund's remaining shareholding is approximately 480 million shares, representing a new ownership percentage of 6.32% [1] - The transaction involves other related parties, including China Chengtong Holdings Group Co., Ltd. and Chengda Holdings Limited [1]

Industry Trends - The global natural uranium market continues to maintain a tight supply-demand balance, with a projected supply-demand gap of 6,000 tons by 2030 and 31,000 tons by 2035 according to UxC [1] - Supply-side challenges include a 9.3% reduction in nominal production from Kazakhstan's uranium mines for 2026 and delays in new mining projects in Niger and West Africa, increasing supply uncertainty [1] - On the demand side, China's nuclear power approvals remain steady, and the U.S. plans to start construction on 10 large nuclear power plants by 2030, driven by surging electricity demand from AI [1] - Global uranium inventories are decreasing, with UxC predicting secondary supply will drop from 11,000 tons in 2025 to 6,000-7,000 tons by 2030, reinforcing the view of a tight supply-demand situation [1] Market Activity - Since May, the natural uranium spot market has seen increased activity, with long-term contract prices showing signs of rising, reflecting expectations of future supply-demand gaps [2] - In the first half of 2025, the spot transaction volume of natural uranium was approximately 10,000 tons, nearing the total volume for 2024, driven by U.S. tariff policy and increased procurement by Sprott Fund [2] - Nuclear power owners accounted for 35% of the spot transaction volume in the first half of the year, as difficulties in long-term contract negotiations pushed them towards the spot market [2] - The expectation of a Federal Reserve interest rate cut in September may lead traders and financial institutions to increase procurement, potentially raising spot prices closer to long-term contract prices [2] Company Trends - The international trade segment's impact may have been concentrated in the first half of the year, with expectations for the second half to recover from previous losses [3] - The company reported a net profit of -68 million HKD in the first half of 2025, a 160% year-on-year decline, primarily due to price fluctuations in international trade contracts and inventory accounting methods [3] - Approximately 55% of contracts delivered in the first half were signed at low prices between 2021-2023, with an average selling price of 48 USD per pound, below the weighted average cost of 60-70 USD per pound [3] - The company anticipates an increase in high-priced contract deliveries starting in the second half of 2025, with 4,256 tons of unsold contracts signed at an average price of 80.8 USD per pound, indicating significant future profit growth potential [3] - The company has adjusted its international trade contracting strategy to shorten delivery cycles, reducing risks associated with price fluctuations and mismatches [3] - Profit forecasts for the company indicate a recovery in net profit for 2025-2027, with expected figures of 348 million, 1.039 billion, and 1.123 billion HKD, corresponding to year-on-year growth rates of +1.84%, +198.42%, and +8.04% [3]

Core Viewpoint - The company reported a decline in performance for the first half of 2025, with revenue and net profit falling significantly compared to the previous year, primarily due to fluctuations in natural uranium prices and increased operational costs [1][2]. Company Performance - In the first half of 2025, the company achieved a revenue of HKD 1.709 billion, a year-on-year decrease of 58% [1]. - The net profit attributable to shareholders was a loss of HKD 68 million, representing a year-on-year decline of 160% [1]. - The main reasons for the loss included high unit sales costs in the natural uranium sales business and a decrease in investment income due to falling uranium prices [1]. Operational Costs - The operational costs for mining significantly increased, with raw material prices, such as sulfur, rising by 24% year-on-year [1]. - The underground resource usage tax in Kazakhstan increased from 6% to 9%, contributing to higher unit costs [1]. - The company's mining sales costs rose by 6% year-on-year, reaching USD 27.9 per pound due to inflation and a 5% increase in labor costs [1]. Market Trends - The global natural uranium market continued to show volatility, with an increase in procurement willingness among nuclear power owners, raising their share of total spot trading volume from 16% in 2024 to approximately 35% [2]. - The long-term trading market faced slow contract signing due to macroeconomic uncertainties and trade policy adjustments [2]. - The supply-demand relationship remained tight in the first half of 2025, influenced by production changes and procurement rhythms, while long-term support is expected from nuclear power expansion and global energy transition [2]. Industry Developments - Kazatomprom announced a production reduction strategy for 2026, planning to cut its nominal production by about 10%, which is expected to support uranium prices [2][3]. - The upcoming World Nuclear Association (WNA) conference in September is anticipated to be a significant catalyst for the industry, potentially refocusing attention on the strategic role of nuclear energy in the energy transition [3]. Profit Forecast - The company, as the only pure uranium listed company in East Asia backed by China General Nuclear Power Group, has revised its net profit forecasts for 2025, 2026, and 2027 to HKD 382 million, HKD 939 million, and HKD 1.181 billion, respectively, reflecting year-on-year growth of 11.7%, 145.9%, and 25.7% [3].

Investment Rating - The investment rating for China General Nuclear Power Corporation (CGN) is "Outperform the Market" [6][4]. Core Views - The report highlights that the average cost of inventory is higher than the international trade sales price, leading to increased losses in trading operations. The company's revenue for the first half of 2025 was HKD 1.709 billion, a decrease of 58.4% year-on-year, primarily due to falling uranium prices and reduced international trade delivery volumes. The net loss attributable to shareholders was HKD 68 million, a year-on-year increase of 159.7% [1][9]. - Uranium production met expectations, with a total extraction of 1,351 tons of uranium (tU) in the first half of 2025, a 1.2% increase year-on-year. However, the international trade business experienced a price inversion due to the company's inventory accounting method [2][11]. - The report expresses optimism about future uranium price trends, citing a tightening supply-demand situation and expectations of a rebound in uranium prices supported by global nuclear power recovery [3][12]. Summary by Sections Financial Performance - In the first half of 2025, the company reported a revenue of HKD 1.709 billion, down 58.4% year-on-year, and a net loss of HKD 68 million, reflecting a significant decline in trading profits due to high inventory costs [1][9]. - The average production cost for uranium was USD 26.69 per pound U3O8, while the average sales price was USD 71.07 per pound U3O8, leading to losses in the trading segment [2][11]. Market Outlook - The report anticipates a recovery in uranium prices due to a combination of supply constraints and increasing demand from the global nuclear power sector. The new long-term sales agreements are expected to support future revenue growth [3][12][13]. Profit Forecast - The profit forecast has been adjusted downward, with expected net profits for 2025-2027 revised to HKD 480 million, HKD 950 million, and HKD 1.09 billion, respectively. The corresponding year-on-year growth rates are projected at 39%, 99%, and 14.4% [4][5].

证券研究报告 中广核矿业 (1164 HK) 2025 年 8 月 29 日│中国香港 其他金属非金属新材料及加工 8 月 28 日中广核矿业（1164 HK）出席了我们组织的 2025 年秋季策略会， 会上公司就天然铀供需格局、现货/长协市场交易量与铀价趋势、公司国际 贸易板块重点分析，以及对未来展望进行了交流。 盈利预测与估值 公司 25H1 国际贸易业务亏损系一次性影响，且 25H2 起公司高价订单交付 和签约策略调整下盈利修复可期，我们维持 25-27 年归母净利 3.48、10.39、 11.23 亿港币（同比+1.84%、+198.42%、+8.04%），对应 EPS 为 0.05、 0.14、0.15 港币。我们参考 Visible Alpha 可比公司 2026 年估值中枢 （22.1xPE），考虑未来现货铀价波动仍存在不确定性，维持公司 2026E 21.5xPE 估值，目标价 3.01 港币。 风险提示：核电事故风险，行业需求不及预期。 2025 年秋季策略会速递—— 国际贸易跨期合约 25H2 起预期改善 核心观点： 华泰研究 动态点评 投资评级(维持): 增持 目标价(港币): 3.0 ...